AC
AMGN icon

ASB Consultores’s Amgen AMGN Stock Holding History

ASB Consultores’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-948
Closed -$270K – 201
2024
Q1 		$270K Buy
+948
New +$277K 0.07% 238
2023
Q1 		– Sell
-1,100
Closed -$289K – 188
2022
Q4 		$289K Buy
1,100
+30
+3% +$8.04K 0.12% 136
2022
Q3 		$241K Hold
1,070
– – 0.11% 143
2022
Q2 		$260K Sell
1,070
-189
-15% -$46.3K 0.11% 126
2022
Q1 		$304K Buy
1,259
+161
+15% +$37K 0.13% 148
2021
Q4 		$247K Buy
+1,098
New +$232K 0.12% 188

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ASB Consultores's AMGN Position: Q2 2024 in Review

ASB Consultores sold out of Amgen (AMGN) in Q2 2024, closing a stake of 948 shares — an estimated $270K sold.

ASB Consultores first reported a position in AMGN in Q4 2021 and held it in 6 quarters. The position peaked at $304K in Q1 2022. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • ASB Consultores reported no remaining Amgen position as of Q2 2024 after selling out during the quarter.
  • ASB Consultores sold 948 Amgen shares in Q2 2024, an estimated $270K.
  • ASB Consultores first reported a position in Amgen in Q4 2021 and held it in 6 quarters.
  • ASB Consultores's Amgen position peaked at $304K in Q1 2022.
  • 2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on ASB Consultores's 13F filing for Q2 2024, filed 12 Aug 2024.